DNDi has formed a consortium with four pharmaceutical companies to hasten the development of drugs for leishmaniasis and Chagas disease.
Japan's Global Health Initiative Technology Fund has committed US$12 million in grants for neglected diseases and a potential tuberculosis vaccine.
The Global Health Innovative Technology Fund, a new public-private partnership, is taking Japanese R&D to the global fight against infectious disease.
A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.
Sanofi and the Drugs for Neglected Diseases initiative will develop new treatments for nine neglected tropical diseases listed by the World Health Organization.